Myomo Mission Statement
- Our goal is to improve the lives of people by providing effective, safe and reliable medical products and services of the highest standard of quality, meeting or exceeding our customer requirements and expectations.
Myomo, Inc. is a medical device company that develops and provides the MyoPro, a powered arm orthosis for people with weakness or partial paralysis in the arm and hand. The company is headquartered in Burlington, Massachusetts, and its products are prescribed and fitted through trained clinical providers across the United States and in select international markets.
Based on patented technology developed at MIT, Harvard Medical School and by the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disabilities. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Published clinical research shows a clinically significant instantaneous reduction in upper extremity impairment through the use of MyoPro. MyoPro is referred for patients at leading rehabilitation facilities, including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Kennedy Krieger Institute, Loma Linda Medical Center and twenty VA hospitals, among others. It is fitted and delivered through a nationwide network of orthotics and prosthetics practices, and over 600 have been used by patients. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S.
Myomo designs, manufactures and delivers myoelectric orthoses — powered braces that read a wearer's own muscle signals to assist arm and hand movement. The company works with clinicians, insurers and patients to evaluate candidates, fit custom devices and support daily use.
The company's devices are used by people with arm weakness or partial paralysis following stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, and certain nerve and neuromuscular conditions, along with the clinicians and rehabilitation facilities who treat them.
Myomo, Inc. is a publicly traded company listed on the NYSE American exchange under the ticker symbol MYO. Financial reports, filings, press releases and shareholder information are available in the investor relations section.